Simplifying Global Compliance
Drug Safety? There (Should Be) an App for That, FDA Says
International Pharmaceutical Regulatory Monitor
The FDA is seeking public comment on how it should regulate prescription drug software apps and says some apps might have to be regulated as a device — such as a software program that uses advanced algorithms to scan skin lesions for evidence of cancer.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor
Buy This Article Now
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing